Stanley C. Erck, President and CEO at NOVAVAX INC (NVAX), sold 104,632 shares at $87.20 ($9.5M) on 2020-11-16, disclosed to the SEC on 2020-11-18.
Open-market sale of $9.5M NVAX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.20 | 5,766 | $503K | 5.3% |
| 2 | $87.20 | 5,766 | $503K | 5.3% |
| 3 | $88.36 | 8,306 | $734K | 7.7% |
| 4 | $88.36 | 8,306 | $734K | 7.7% |
| 5 | $89.26 | 11,234 | $1.0M | 10.6% |
| 6 | $89.26 | 11,234 |
| $1.0M |
| 10.6% |
| 7 | $90.61 | 4,598 | $417K | 4.4% |
| 8 | $90.61 | 4,598 | $417K | 4.4% |
| 9 | $92.97 | 17,503 | $1.6M | 17.2% |
| 10 | $92.97 | 17,503 | $1.6M | 17.2% |
| 11 | $93.56 | 4,909 | $459K | 4.8% |
| 12 | $93.56 | 4,909 | $459K | 4.8% |
| Total | $90.65 avg | 104,632 | $9.5M | 100% |
| Filing → |
| MXCT | SELL | 2024-10-02 | $358K | — | Filing → |
| MXCT | SELL | 2024-09-05 | $383K | — | Filing → |
| NVAX | SELL | 2021-10-05 | $16.6M | — | Filing → |